Status:
COMPLETED
Panaceo "MED" for IBS (Irritable Bowel Syndrome)
Lead Sponsor:
Scigenia GmbH
Conditions:
Irritable Bowel Syndrome
Microbial Colonization
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Zeolite clinoptilolite is a volcanic mineral from the group of zeolites. The porous structure is associated with a large inner surface. Due to the anionic framework charge, ions (e.g., Pb\^2+) can be ...
Eligibility Criteria
Inclusion
- Frequency of discomfort or pain in the abdomen in the last 3 months, more than 1 day per week.
- Start of the discomfort or pain more than 6 months ago.
- Improvement of the discomfort or pain associated with bowel movements sometimes, often, frequently, always.
- Association of the discomfort or pain with a frequency change in bowel movements sometimes, often, frequently, always.
- Association of the discomfort or pain with a change in stool-consistency sometimes, often, frequently, always.
Exclusion
- Age: younger than 18, older than 80.
- Diagnosed inflammatory bowel disease (M. Crohn, Colitis Ulcerosa)
- Diagnosed nutritional idiosyncrasy
- Cancer treatment in the last 12 weeks
- Depression in the last 12 weeks
- Intake of weight loss supporting medication (Lipase inhibitors)
- Alcohol, nicotine, drug-abuse
- Status after organ-transplantation, intake of immunosuppressants
- Acute or chronic neurologic or psychiatric disease
- Acute or chronic heart disease or kidney disease
- Acute or chronic liver damage or any other organ damages
- Transient severe obstipation in the last 4 weeks
- Transient acute diarrhea in the last 4 weeks (e.g. intestinal infection)
- Intestinal cancer
- Intake of Panaceo MED or other Zeolite in the last 4 weeks
- Type I Diabetes or severe metabolic disease
- Infection with fever in the last 4 weeks
- Intake of cortisone or antibiotics in the last 4 weeks
- Planed journey of more than 14 days in the next 12 weeks (change of nutritional habits)
Key Trial Info
Start Date :
March 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT03817645
Start Date
March 9 2018
End Date
June 30 2020
Last Update
March 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SCIgenia GmbH
Vienna, Austria, 1090